Table 2.
Description of medical treatment for the Addison’s patient group and the type 2 diabetes group.
| Variable | Addison’s female | Addison’s male | Diabetes male | Diabetes female | Total | |
|---|---|---|---|---|---|---|
| Fludrocortisone replacement | Yes No |
7 1 |
8 0 |
0 8 |
0 8 |
15 17 |
| Hydrocortisone replacement | Yes No |
8 0 |
8 0 |
0 8 |
0 8 |
16 16 |
| Thyroxine replacement | Yes No |
4 4 |
3 5 |
0 8 |
0 8 |
7 25 |
| DHEA replacement | No | 8 | 8 | 8 | 8 | 32 |
| Oral anti-diabetic drugs | Yes No |
0 8 |
0 8 |
6 2 |
5 3 |
11 21 |
| Insulin | Yes No |
0 8 |
0 8 |
5 3 |
5 3 |
10 22 |
| Antihypertensive drugs | Yes No |
3 5 |
4 4 |
7 1 |
7 1 |
21 11 |
| Other treatment | Yes No |
6 2 |
6 2 |
8 0 |
5 3 |
25 7 |